MAP2K7 and hepatocellular carcinoma: However, YTHDF2 functioned as a tumor suppressor in HCC via destabilization of epidermal growth factor receptor (EGFR) mRNA89, leading to the inhibition of the ERK/MEK signaling pathway in HCC.